Portside Wealth Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$525K Sell
6,356
-34
-0.5% -$3.01K 0.06% 302
2026
Q2
$613K Buy
6,390
+87
+1% +$8.92K 0.07% 265
2026
Q1
$688K Buy
6,303
+163
+3% +$15.5K 0.09% 211
2025
Q4
$498K Sell
6,140
-206
-3% -$17.7K 0.07% 264
2025
Q3
$555K Buy
6,346
+443
+8% +$39.6K 0.08% 237
2025
Q2
$490K Buy
5,903
+487
+9% +$40.7K 0.07% 251
2025
Q1
$454K Sell
5,416
-678
-11% -$63.1K 0.07% 240
2024
Q4
$562K Buy
6,094
+742
+14% +$71.4K 0.09% 211
2024
Q3
$497K Buy
+5,352
New +$464K 0.08% 227

Other funds holding LMAT

Portside Wealth Group's LMAT Position: Q3 2026 in Review

Portside Wealth Group reduced its LeMaitre Vascular (LMAT) stake by 0.53% in Q3 2026, selling an estimated $3.01K and leaving 6,356 shares worth $525K. The position accounts for 0.06% of the portfolio, ranked #302.

Portside Wealth Group first reported a position in LMAT in Q3 2024 and has held it in 9 quarters since. The position peaked at $688K in Q1 2026. 28 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Portside Wealth Group held 6,356 shares of LeMaitre Vascular worth $525K as of Q3 2026.
  • Portside Wealth Group sold 34 LeMaitre Vascular shares in Q3 2026, an estimated $3.01K.
  • LeMaitre Vascular made up 0.06% of Portside Wealth Group's portfolio in Q3 2026, its #302 holding.
  • Portside Wealth Group first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 9 quarters since.
  • Portside Wealth Group's LeMaitre Vascular position peaked at $688K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.